Exit-Covid-19
The FDA approved a Phase II trial for ExoFlo to treat patients with COVID-19. EXIT COVID-19 is a...
Read MoreThe FDA approved a Phase II trial for ExoFlo to treat patients with COVID-19. EXIT COVID-19 is a...
Read MoreFDA Approval for EXIT-COVID-19 Source Reference The FDA approved a Phase II trial to use the...
Read MoreNeurologic Stem Cell Treatment Study Researchers from the National Institute of Health are...
Read MorePatients with Covid-19 recover during clinical trial Source Reference Doctors are testing...
Read MoreMesenchymal Stem Cells in the Treatment of Subjects with Advanced Chronic Obstructive Pulmonary...
Read More